Morepen Laboratories Ltd
MOREPENLABMorepen Laboratories Ltd
MOREPENLABPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
31.00 | 3.14 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.76 | 5.90 | 0.56% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Morepen Laboratories Limited is a pharmaceutical company. The Company operates through four segments; they are Active Pharmaceutical Ingredients (API), Domestic Formulations, Diagnostics and Over the Counter (OTC).
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 402.01 | 486.29 | 599.19 | 610.23 | 772.21 | 862.55 | 1,200.13 | 1,557.14 | 1,423.66 | 1,643.90 | ||||||||||
Raw Materials | 244.81 | 303.71 | 381.14 | 365.10 | 516.38 | 567.65 | 822.13 | 1,059.36 | 939.26 | 1,505.25 | ||||||||||
Power & Fuel Cost | 7.41 | 7.64 | 9.84 | 11.08 | 13.18 | 12.56 | 13.00 | 18.93 | 23.78 | |||||||||||
Employee Cost | 48.79 | 58.29 | 69.69 | 76.53 | 95.36 | 109.91 | 135.59 | 164.25 | 154.68 | |||||||||||
Selling & Administrative Expenses | 38.70 | 43.72 | 53.46 | 61.08 | 73.30 | 81.73 | 92.40 | 102.60 | 123.94 | |||||||||||
Operating & Other expenses | 12.70 | 14.56 | 19.96 | 27.99 | 2.80 | 12.70 | 6.43 | 65.01 | 96.33 | |||||||||||
EBITDA | 49.60 | 58.37 | 65.10 | 68.45 | 71.19 | 78.00 | 130.58 | 146.99 | 85.67 | 138.65 | ||||||||||
Depreciation/Amortization | 38.67 | 35.20 | 33.90 | 34.32 | 39.90 | 36.91 | 30.28 | 27.64 | 27.93 | 30.83 | ||||||||||
PBIT | 10.93 | 23.17 | 31.20 | 34.13 | 31.29 | 41.09 | 100.30 | 119.35 | 57.74 | 107.82 | ||||||||||
Interest & Other Items | 8.66 | 10.50 | 7.56 | 4.36 | 2.11 | 1.98 | 1.79 | -7.37 | 1.98 | 3.47 | ||||||||||
PBT | 2.27 | 12.67 | 23.64 | 29.77 | 29.18 | 39.11 | 98.51 | 126.72 | 55.76 | 104.35 | ||||||||||
Taxes & Other Items | 0.14 | -0.13 | 0.00 | 0.18 | 0.33 | 5.53 | 1.42 | 25.02 | 17.08 | 28.24 | ||||||||||
Net Income | 2.13 | 12.80 | 23.64 | 29.59 | 28.85 | 33.58 | 97.09 | 101.70 | 38.68 | 76.11 | ||||||||||
EPS | 0.05 | 0.28 | 0.53 | 0.66 | 0.64 | 0.75 | 2.16 | 2.19 | 0.78 | 1.49 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Morepen Laboratories Ltd | 60.99 | 3.14 | — |
Sun Pharmaceutical Industries Ltd | 43.54 | 6.22 | 0.75% |
Cipla Ltd | 39.63 | 4.68 | 0.62% |
Dr Reddy's Laboratories Ltd | 22.35 | 4.33 | 0.66% |
Price Comparison
Compare MOREPENLAB with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Decreased Total Retail Holding
In last 3 months, retail holding in the company has decreased by 1.35%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
MOREPENLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
News & Opinions
Muthoot Finance, Morepen Laboratories, and Force Motors: What the Charts Say
11 months ago•The Hindu Businessline
Gati Ltd leads losers in ‘A’ group
1 year ago•Business Standard
Morepen Laboratories Ltd leads losers in ‘A’ group
1 year ago•Business Standard
Morepen Laboratories Ltd leads gainers in ‘A’ group
1 year ago•Business Standard
Morepen Laboratories Ltd leads gainers in ‘A’ group
1 year ago•Business Standard
UCO Bank leads gainers in ‘A’ group
1 year ago•Business Standard
MSTC Ltd leads gainers in ‘A’ group
1 year ago•Business Standard
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 18.46%, vs industry avg of 8.36%
Increasing Market Share
Over the last 5 years, market share increased from 0.3% to 0.44%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 5.5%, vs industry avg of 9.82%